<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03132727</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL16_0632</org_study_id>
    <nct_id>NCT03132727</nct_id>
  </id_info>
  <brief_title>Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer</brief_title>
  <acronym>Larynx MRI</acronym>
  <official_title>Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if MRI can detect preoperative invasion of cartilage by laryngeal and
      hypopharyngeal carcinoma, and to compare it to CT imaging and histopathology in excised
      larynges and/or hypopharynges.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2017</start_date>
  <completion_date type="Anticipated">May 23, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 23, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endoscopy</measure>
    <time_frame>1-4 weeks</time_frame>
    <description>Tumor stage and cartilage invasion as determined by endoscopy : invaded/non invaded/undetermined</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CT scan</measure>
    <time_frame>1-4 weeks</time_frame>
    <description>Tumor stage and cartilage invasion as determined by CT scan : invaded/non invaded/undetermined</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MRI</measure>
    <time_frame>1-4 weeks</time_frame>
    <description>Tumor stage and cartilage invasion as determined by MRI : invaded/non invaded/undetermined</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anatomopathological analysis</measure>
    <time_frame>2-4 weeks</time_frame>
    <description>Tumor stage and cartilage invasion as determined by histopathology in excised pieces : invaded/non invaded/undetermined</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hypopharyngeal Carcinoma</condition>
  <condition>Laryngeal Carcinoma</condition>
  <arm_group>
    <arm_group_label>Pharyngo laryngeal MRI</arm_group_label>
    <description>Patient with a laryngeal or hypopharyngeal cancer at any stage, with a doubt about cartilage invasion and eligible for surgical treatment for which there is an indication for performing an MRI in addition to CT at the discretion of the investigator</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharyngo laryngeal MRI</intervention_name>
    <description>Patients will be outgoing a pharyngolaryngeal MRI, with injection of gadolinium, in addition to the CT imaging. They will have this MRI in case of doubt about cartilage invasion. It will be realised during the time between the CT imaging and the day of surgery.
Device : gadolinium-based MRI contrast agent This will be realized according to the standard procedure.</description>
    <arm_group_label>Pharyngo laryngeal MRI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with a laryngeal or hypopharyngeal cancer at any stage, with a doubt about
        cartilage invasion and eligible for surgical treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient ≥18 years old

          -  Patient with a laryngeal or hypopharyngeal cancer at any stage

          -  Patient eligible for a surgical treatment in multidisciplinary consultation

          -  Patient who did not oppose its participation to the study

          -  Indication for performing an MRI in addition to CT at the discretion of the
             investigator

        Exclusion Criteria:

          -  Patient with an ASA (&quot;American Society of Anesthesiologists&quot;, international anesthesia
             classification) score ≥ 3,

          -  Patient with a chirurgical contraindication

          -  Patient with a MRI contraindication

          -  Pregnant or nursing woman

          -  Adult requiring protection (guardianship, supervision)

          -  Patient participating in interventional research (Excluding physiological studies and
             interventional research involving only minimal risks and constraints that do not
             interfere with the analysis of the primary outcome).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe CERUSE, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service ORL et chirurgie cervico-faciale, Hôpital de la Croix rousse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe CERUSE, Pr</last_name>
    <phone>04 26 73 27 70</phone>
    <phone_ext>+33</phone_ext>
    <email>philippe.ceruse@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service ORL et chirurgie cervico-faciale, Hôpital de la Croix rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe CERUSE, Pr</last_name>
      <phone>04 26 73 27 70</phone>
      <phone_ext>+33</phone_ext>
      <email>philippe.ceruse@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <last_update_submitted>May 11, 2017</last_update_submitted>
  <last_update_submitted_qc>May 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Hypopharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

